DeepMed Research

UNIVERSITY OF KENTUCKY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1865-01-01

Employees: 10K

Market Cap: -

Website: http://www.uky.edu

Clinical Trials

Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor

Phase 1

Completed

Conditions: Community Acquired Pneumonia
Hospital Acquired Pneumonia
Pneumonia
Acute Lung Injury

Interventions: Drug: placebo
Drug: ticagrelor

First Posted Date: 2013-06-21

Last Posted Date: 2018-09-13

Lead Sponsor: University of Kentucky

Target Recruit Count: 60

Registration Number: NCT01883869

Locations: 🇺🇸
University of Kentucky Hospitals, Lexington, Kentucky, United States
🇺🇸
University of Kentucky Hospital, Lexington, Kentucky, United States

Evaluation of Green Dot a Primary Prevention Intervention

Not Applicable

Completed

Conditions: Sex Offenses

Interventions: Behavioral: Control
Behavioral: Green Dot Bystander Intevention

First Posted Date: 2013-06-14

Last Posted Date: 2019-03-15

Lead Sponsor: University of Kentucky

Target Recruit Count: 89707

Registration Number: NCT01878097

Locations: 🇺🇸
University of Kentucky, Lexington, Kentucky, United States

Buspirone as a Candidate Medication for Methamphetamine Abuse

Phase 1

Completed

Conditions: Methamphetamine Dependence
Methamphetamine Abuse

Interventions: Drug: Methamphetamine
Drug: Placebo

First Posted Date: 2013-04-30

Last Posted Date: 2018-02-07

Lead Sponsor: University of Kentucky

Target Recruit Count: 9

Registration Number: NCT01843205

Locations: 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States

Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva

Not Applicable

Completed

Conditions: Dry Mouth

Interventions: Drug: Cevimeline
Drug: Pilocarpine

First Posted Date: 2012-09-21

Last Posted Date: 2018-06-04

Lead Sponsor: University of Kentucky

Target Recruit Count: 15

Registration Number: NCT01690052

Locations: 🇺🇸
University of Kentucky Orofacial Pain Center College of Dentistry, Lexington, Kentucky, United States

Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

Not Applicable

Withdrawn

Conditions: Renal Transplant

Interventions: Drug: Zortress® /Everolimus

First Posted Date: 2012-06-05

Last Posted Date: 2017-08-07

Lead Sponsor: University of Kentucky

Registration Number: NCT01612299

Locations: 🇺🇸
University of Kentucky, Lexington, Kentucky, United States

A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction

Phase 4

Completed

Conditions: Mastectomy Related Lymphedema
Breast Reconstruction
Breast Cancer

Interventions: Procedure: AlloDerm
Procedure: Dermal Autograft

First Posted Date: 2012-03-23

Last Posted Date: 2016-05-11

Lead Sponsor: University of Kentucky

Target Recruit Count: 48

Registration Number: NCT01561287

Locations: 🇺🇸
University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States

A Prospective Trial on the Effects of Vitamin D Supplementation in Collegiate Swimmers and Divers

Phase 3

Completed

Conditions: Healthy

Interventions: Dietary Supplement: Vitamin D
Dietary Supplement: Placebo

First Posted Date: 2011-12-08

Last Posted Date: 2013-02-25

Lead Sponsor: University of Kentucky

Target Recruit Count: 45

Registration Number: NCT01488227

Locations: 🇺🇸
University of Kentucky, Lexington, Kentucky, United States

Trunk Strength Study

Completed

Conditions: Ventral/Incisional Hernia Repairs

First Posted Date: 2011-02-23

Last Posted Date: 2011-03-11

Lead Sponsor: University of Kentucky

Target Recruit Count: 10

Registration Number: NCT01300936

Locations: 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States

The Effect of Nutrisystem Meal Provision on Weight

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Nutrisystem

First Posted Date: 2010-12-02

Last Posted Date: 2011-06-23

Lead Sponsor: University of Kentucky

Target Recruit Count: 50

Registration Number: NCT01252303

Locations: 🇺🇸
University of Kentucky, Lexington, Kentucky, United States

A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & 15 of an Every 21-day Cycle in Adult Patients With Refractory or Metastatic Solid Malignancies

Phase 1

Completed

Conditions: Solid Malignancies

Interventions: Drug: 7-t-butyldimethylsilyl-10-hydroxycamptothecin

First Posted Date: 2010-09-15

Last Posted Date: 2013-08-14

Lead Sponsor: University of Kentucky

Target Recruit Count: 3

Registration Number: NCT01202370

Locations: 🇺🇸
Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy